Kenya PPB warns on fake Postinor-2
Analysis based on 9 articles · First reported Aug 13, 2026 · Last updated Aug 14, 2026
The alert may temporarily reduce consumer trust in emergency contraceptives in Kenya, potentially affecting sales of Postinor-2 and similar products. Gedeon Richter, the legitimate manufacturer, faces reputational risk and potential revenue impact from counterfeit competition, though the company is not implicated in wrongdoing.
The Kenya — Pharmacy and Poisons Board (PPB) of Kenya issued a public alert warning about a falsified batch of Postinor-2 emergency contraceptive pills (levonorgestrel 0.75 mg, batch T34197R) circulating in the Kenyan market. The counterfeit product falsely claims to be manufactured by Gedeon Richter. PPB identified multiple differences from genuine packs, including batch printing, patient information leaflet errors, carton sealing, color intensity, and authentication logo font. The regulator warned that the fake pills may contain incorrect active ingredient amounts, no active ingredient, harmful contaminants, or undeclared substances, posing health risks. PPB advised healthcare professionals to verify stock authenticity and quarantine suspected products, and urged the public and supply chain actors to report encounters. Investigations led to the arrest of two individuals in possession of the falsified product. PPB also reminded suppliers to procure only from licensed sources, citing the Pharmacy and Poisons Act. Tharaka Nithi Governor Muthomi Njuki separately expressed concern about fake P2 pills and falsified HIV testing kits.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard